Oriola-KD Corporation Stock Exchange Release 16 December 2011 at 8.30 a.m.
Guidelines issued on 19 July 2011
Oriola-KD's net sales are expected to increase over 10 per cent in 2011 compared to the previous year. Operating profit excluding one-off items and impairment
charges is expected to exceed EUR 20 million in 2011.
New guidelines issued on 16 December 2011
Oriola-KD's net sales are expected to increase approximately 11 per cent in 2011 compared to the previous year. Operating profit excluding one-off items and impairment charges is expected to be EUR 12-15 million in 2011.
The operating loss of the pharmaceutical businesses in Russia, and especially of pharmaceutical wholesale, for the full year 2011 decreases significantly Oriola-KD's operating profit in 2011.
Oriola-KD Corporation
Eero Hautaniemi
President and CEO
Kimmo Virtanen
Executive Vice President and CFO
Further information:
Kimmo Virtanen
Executive Vice President and CFO
tel. +358 (0)10 429 2069
e-mail: kimmo.virtanen@oriola-kd.com
Pellervo Hämäläinen
Vice President, Communications and Investor Relations
tel. +358 (0)10 429 2497
e-mail: pellervo.hamalainen@oriola-kd.com
Distribution
NASDAQ OMX Helsinki Ltd
Principal media
Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola-kd.com
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Oriola-KD Oyj via Thomson Reuters ONE
